The systemic immune inflammation index (SII; platelet count x neutrophil-lymphocyte ratio), a new marker, predicts adverse clinical outcomes in many conditions, including acute and chronic coronary syndromes, pulmonary embolism, cancers, and contrast nephropathy. The aim of this study was to determine the relationship between SII and microvascular dysfunction in patients with Cardiac Syndrome X (CSX); 105 patients with CSX and 105 patients with normal coronary arteries were included. Microvascular dysfunction was determined angiographically using myocardial blush grade (MBG) and total myocardial blush score (TMBS). We observed that the SII levels were higher in the CSX (+) group (687 [355–2211] vs 418 [198–1614], P<.001). The SII levels were also found to be significant independent predictors for CSX in multiple regression analysis (P=.001). SII levels >440 had 83.8% sensitivity and 55.2% specificity (area under the curve [AUC]: .923, 95% CI: .895–.999, P<.001) for predicting CSX. There is a significant correlation between SII levels and CSX.
ScholzMWegenerKUnverdorbenMKlepzigH. Langzeitprognose von patienten mit angina-pectoris-beschwerden und angiographisch normalen koronararterien. Herz2003; 28: 413–420.
3.
HurstTOlsonTHOlsonLEAppletonCP. Cardiac syndrome X and endothelial dysfunction: new concepts in prognosis and treatment. Am J Med2006; 119: 560–566.
4.
Recio-MayoralARimoldiOECamiciPGKaskiJC. Inflammation and microvascular dysfunction in cardiac syndrome X patients without conventional risk factors for coronary artery disease. JACC Cardiovasc Imaging2013; 6: 660–667.
5.
AtmacaYOzdemirAOOzdolC, et al.Angiographic evaluation of myocardial perfusion in patients with syndrome X. Am J Cardiol2005; 96: 803–805.
6.
MontecuccoFLiberaleLBonaventuraAVecchièADallegriFCarboneF. The role of inflammation in cardiovascular outcome. Curr Atheroscler Rep2017; 19: 11.
7.
AtmacaYOzdolCTurhanSVurgunKDuzenVErdolC. The association of elevated white blood cell count and C-reactive protein with endothelial dysfunction in cardiac syndrome X. Acta Cardiol2008; 63: 723–728.
8.
OkyayKYilmazMYildirirA, et al.Relationship between neutrophil-to-lymphocyte ratio and impaired myocardial perfusion in cardiac syndrome X. Eur Rev Med Pharmacol Sci2015; 19: 1881–1887.
9.
DemirkolSBaltaSCelikT, et al.Assessment of the relationship between red cell distribution width and cardiac syndrome X. Kardiol Pol2013; 71: 480–484.
10.
DoganAOylumluM. Increased monocyte-to-HDL cholesterol ratio is related to cardiac syndrome X. Acta Cardiol2017; 72: 516–521.
11.
DemirkolSBaltaSUnluM, et al.Evaluation of the mean platelet volume in patients with cardiac syndrome X. Clinics2012; 67: 1019–1022.
12.
LiSLiuKGaoY, et al.Prognostic value of systemic immune-inflammation index in acute/subacute patients with cerebral venous sinus thrombosis. Stroke Vasc Neurol2020; 5: e000362.
13.
YangYLWuCHHsuPF, et al.Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest2020; 50: e13230.
14.
NieDGongHMaoXLiZ. Systemic immune-inflammation index predicts prognosis in patients with epithelial ovarian cancer: a retrospective study. Gynecol Oncol2019; 152: 259–264.
15.
SeoMYamadaTMoritaT, et al.Prognostic value of systemic immune-inflammation index in patients with chronic heart failure. Eur Heart J2018; 39.
16.
HuangJZhangQWangR, et al.Systemic immune-inflammatory index predicts clinical outcomes for elderly patients with acute myocardial infarction receiving percutaneous coronary intervention. Med Sci Mon Int Med J Exp Clin Res2019; 25: 9690–9701.
17.
ManciaGFagardRNarkiewiczK, et al.2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press2014; 23: 3–16.
18.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care2014; 37: 81–90.
19.
HoorntjeJCAde BoerMJZijlstraF, et al.Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation1998; 97: 2302–2306.
20.
AtmacaYDuzenVOzdolC, et al.Total blush score: a new index for the assessment of microvascular perfusion in idiopathic dilated cardiomyopathy. Coron Artery Dis2008; 19: 181–185.
CoxIDBøtkerHEBaggerJPSonneHSKristensenBØKaskiJC. Elevated endothelin concentrations are associated with reduced coronary vasomotor responses in patients with chest pain and normal coronary arteriograms. J Am Coll Cardiol1999; 34: 455–460.
23.
KaskiJC. Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X). Circulation2004; 109: 568–572.
24.
SucatoVNovoGEvolaSNovoS. Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome. Int J Cardiol2015; 186: 96–97.
25.
KatsikiNMikhailidisDP. Perivascular adipose tissue: pathophysiological links with inflammation, atherosclerosis, and thrombosis. Angiology2021; 73: 195–196. doi: 10.1177/00033197211014676.
26.
Recio-MayoralAMasonJCKaskiJCRubensMBHarariOACamiciPG. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J2009; 30: 1837–1843.
27.
BaltaSCelikTMikhailidisDP, et al.The relation between atherosclerosis and the neutrophil-lymphocyte ratio. Clin Appl Thromb Hemost2016; 22: 405–411.
28.
TenekeciogluEYilmazMDemirS, et al.HDL-cholesterol is associated with systemic inflammation in cardiac syndrome X. Minerva Medica2015; 106: 133–141.
29.
Yuri GasparyanAAyvazyanLMikhailidisDPKitasGD. Mean platelet volume: a link between thrombosis and inflammation?Curr Pharmaceut Des2011; 17: 47–58.
30.
PafiliKPenlioglouTMikhailidisDPPapanasN. Mean platelet volume and coronary artery disease. Curr Opin Cardiol2019; 34: 390–398.
31.
ErdoğanMErdölMAÖztürkSDurmazT. Systemic immune-inflammation index is a novel marker to predict functionally significant coronary artery stenosis. Biomarkers Med2020; 14: 1553–1561.
32.
HuangYGaoYWuYLinH. Prognostic value of systemic immune-inflammation index in patients with urologic cancers: a meta-analysis. Cancer Cell Internat2020; 20: 499.
33.
BağcıAAksoyFBaşHA, Systemic immune-inflammation index may predict the development of contrast-induced nephropathy in patients with st-segment elevation myocardial infarction. Angiology2021; 73(3): 218–224. doi: 10.1177/00033197211030053.
34.
ÖztürkRİnanDGüngörB. Systemic immune-inflammation index is a predictor of contrast-induced nephropathy in patients with st-segment elevation myocardial infarction. Angiology2021; 73(2): 125–131. DOI: 10.1177/00033197211029094.
35.
GokMKurtulA. A novel marker for predicting severity of acute pulmonary embolism: systemic immune-inflammation index. Scand Cardiovasc J2020; 55(2): 91–96. doi: 10.1080/14017431.2020.1846774.
36.
EsenboğaKKurtulAYamantürkYYTanTSTutarDE. Systemic immune-inflammation index predicts no-reflow phenomenon after primary percutaneous coronary intervention. Acta Cardiol2021;59-651–8. doi: 10.1080/00015385.2021.1884786.
37.
SchindlerTHSchelbertHRQuercioliADilsizianV. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovasc Imaging2010; 3: 623–640.
38.
LinFYShawLJDunningAM, et al.Mortality risk in symptomatic patients with nonobstructive coronary artery disease. J Am Coll Cardiol2011; 58: 510–519.
